This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Field medical affairs representatives or medicalscience liaisons (MSLs) are responsible for driving bi-directional scientific exchange with key opinion leaders (KOLs). The good news is many data sources are available to help inform decision-making. It’s a lot to juggle. But that’s just the beginning.
The sales and marketing landscape for pharmaceuticals has been changing for some time thanks to the wealth of information now available online for doctors to access at their leisure – but face to face information and education is still as important as ever when exploring new pharmaceutical products.
Are you ready to explore the fascinating world of MedicalScience Liaisons (MSLs) in the pharmaceutical industry ? MSLs are considered the experts in scientific and medicalinformation and they are responsible for building relationships with healthcare professionals.
Medicalscience Liaisons know that change is coming; How are they cashing in? Medicalscience liaisons (MSLs) within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering. positive, negative, neutral) defined according to the organization’s strategic objectives.
This is a dynamic era where clinicians can now be liberated to become enthused, even excited, about the potential to experience a learning journey rather than being on the receiving end of one-off information disposals. We know that improving an HCPs clinical confidence will result in positively affecting their behavior.
While medicalscience advances, too many clinics still rely on cumbersome paperwork. They streamline the process of collecting essential patient information by automating data entry. These forms collect essential information, such as demographics, insurance details, medical history, and reason for visit.
The resulting data offer a view into physician information needs at two critical junctures—during diagnosis and treatment selection. “We physicians are running into challenges around the diagnosis and treatment phase of specific diseases, and so express a need for information that will help them in each phase of the disease progression.”.
Triggered both by the industry-wide digital transformation and by the impacts of the COVID-19 pandemic, HCPs’ expectations for the ways they receive information from pharma partners have shifted. Where medical communications have historically centred on brand, providers now desire more tailored, science-driven messaging.
As medical treatments become more complex, the role of the MedicalScience Liaison (MSL) has never been more important. Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology.
NEJM is pleased to participate in an innovative new service from CCC that aligns with our goal to meet the information needs of researchers for the highest quality studies in medicalscience,” said Rob McKinney, Director, NEJM Group Licensing.
By actively participating in their own learning, patients are more likely to retain information, ask informed questions, and feel more confident in managing their health. Textbooks can be dense and passive, while lectures can deliver information in a one-sided manner that fails to cater to diverse learning styles.
The primary purpose of MedicalScience Liaison MSL is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders KOL’s, at major academic institutions and clinics. This advantage gives MSLs the insights into the customer’s needs as the KOLs are willing to reveal more information.
The old multichannel approach to medical and commercial strategy is no longer as effective as it once was. Simply blitzing doctors and consultants with as much information as possible fails to drive engagement when many healthcare professionals struggle to stay on top of the information required to excel in their day-to-day jobs.
Additionally, approximately 88% of the population looking for medicalinformation turns to the internet. As a result, creating appropriate marketing strategies serves to extract benefits from this opportunity and facilitates the smooth functioning of medical facilities. Importance of Marketing Strategies in Healthcare Systems.
This type of practice can make a measurable difference for pharmaceutical sales teams, where conversations often involve complex clinical information. Medicalscience liaisons (MSLs), account managers, and sales reps all play a role in customer conversations, but the message can become inconsistent if they arent aligned.
One of the biggest challenges for MSLs is finding accurate, real-time information on KOLs in the healthcare industry. This is particularly important due to the high value of an interaction between medicalscience liaisons (MSLs) and (key opinion leaders) KOLs. The answer to these questions is yes.
Seamless data sharing between clinical teams and medicalscience liaisons, for example, could greatly influence clinical trial site selection and ensure more coordinated engagement. Companies like Bayer are already using this type of patient engagement data to inform and enrich conversations with providers. About the authors.
Medical publications are often highly valued by doctors because they are essential to their professional practice and continuous education. The main source of new and up-to-date information on medical research, clinical trials, treatment recommendations, and developments in medicalscience is medical journals.
To justify investment in medical affairs, it’s important to demonstrate impact and align stakeholders with different priorities. This requires identifying meaningful metrics, recognizing their limitations, and using them to inform strategy and decision-making. Measuring medical affairs success is challenging. demonstrates value.
These were not just articles about COVID-19, but the intensity of the research effort in the face of this global crisis was broadly observed by researchers in informationscience (for example: here , and here ). Journal Citation Reports can help you understand key citation impact trends to inform your publishing strategy.
In recent years, there has been an increased focus on real world evidence to advance medicalscience and improve patient quality of life. For more information on how Clarivate can help you get intelligent insights faster, visit Real world data | Medical claims & EHR data | Clarivate.
As evaluators increasingly emphasize the real-world outcomes of basic research, Web of Science profiles help researchers highlight the innovations built upon their work, citing patent information as evidence.
The definition of an “insight” is inconsistent as per the medical affairs function. A medical insight can take many forms, including sentiment, individual perceptions, data points, and trends within healthcare. But, many MSLs struggle to understand the difference between an insight and information shared by a KOL.
Second, adopting a single sourcing strategy creates more risk, explains Liz Breen, PhD, professor at the University of Bradford’s School of Pharmacy and MedicalSciences. In the US, dobutamine is produced by Baxter Healthcare, a subsidiary of Baxter International, and Hospira, a manufacturer of generic injectables acquired by Pfizer.
Where clinicians once received information primarily from books, journals, and peers, HCPs today rely heavily on the digital delivery of new information. The pandemic has also disrupted how HCPs interact with their colleagues and pharma in sharing information. One must choose words carefully.
In commercial, issues related to Medical, Legal, and Regulatory (MLR) review compliance will need to be carefully managed as well. And while it is still too early to predict exactly how generative AI/LLMs will specifically impact pharmaceutical commercialization, several promising use cases are already emerging.
Without the imperative of immediate commercial outcomes, Field Medical Affairs also exists as a trusted relationship-builder in which medicalscience liaisons (MSLs) and healthcare providers (HCPs) can discuss treatment possibilities and scientific concerns candidly. Reference: The Future of HCP Engagement Impact. EPG Health.
MedicalScience Liaisons are hired or contracted to meet with these stakeholders prior to and during the launch and distribution period to educate and create awareness of the drug. Secondary: These are those who will ultimately determine the lifecycle and success of advanced treatments, diagnostic tools, and medications.
Using a book example: Once you define that a web page is about a book, you can then logically add the attributes of that book: author, publishing date, cover, and other information relevant to that book. Include all relevant information. product details, medical specialties, reviews, ratings, availability).
We are bombarded with endless notifications, emails, alerts, and messages, and, coupled with unlimited access to a wealth of information, the volume of online noise is undeniable. Takeda Connect provides oncologists with information about their Key Account Manager and MedicalScience Liaison, alongside direct access at the click of a button.
make patient’s health information available online within a short period of time, facilitate the electronic exchange of health information to improve the quality of care delivered, and submit clinical quality data to reimbursement authorities as required). Advance MedicalScience.
Healthcare providers (HCPs), payers, and patients can now access medicalinformation at their fingertips and they expect more from Pharma than in the past. However, MA must play a critical role in ensuring that digital information is factual, relevant, digestible, and tailored to the intended audience.
Medicalscience liaisons and medical affairs personnel are becoming increasingly important customer-facing components of the team, as sales rep access continues to be limited. We’re seeing brands increase budgets for Medical Affairs,” says Stewart Young, SVP, Strategic Planning, Intouch Proto.
In a pharmaceutical company, medical representatives are responsible for advertising the company's products, but in reality, they are a channel for passing information to the "medical fraternity." In short, MSR are used by manufacturers and distributors to inform doctors about their products.
While MSLs usually aim to portray a company favorably, it is their ultimate objective to provide accurate and unadulterated information. This, however, contains a minimal amount of information. Scan through the company’s investor section for detailed, up-to-date, and accurate information. Background Research. These may include.
Derek Choy The Fine-Tuning API (Application Programming Interface) in OpenAI now enables the creation of hyper-personalized content to support brand managers, customer experience professionals, sales teams, and medicalscience liaisons. to inform HCP engagement strategy.
Combined with the incentives provided by the Orphan Drug Act, a powerful dynamic is at play, ever further pushing the limits of what medicalscience can achieve. Patients value content that serves them—content that’s informative and motivating. Accelerating the Path to Diagnosis and Treatment.
This engagement is continuing to remain high, with evolving requirements and preferences of healthcare practitioners (HCPs) in the ways they engage with pharma reps and medicalscience liaisons (MSLs) through virtual communications. Five steps to closing the CX gap with HCPs and Patients.
Where feasible and appropriate, head-to-head (H2H) trials should be the standard to better inform and accelerate decision-making. Previously, he spent more than 10 years at Roche in multiple positions within medical affairs. Dr Mieke Borgs has been Head of Clinical Operations Europe at BeiGene since May 2020.
Structuring Your Entry-Level Resume A well-structured entry-level resume ensures that your information is presented clearly and effectively. Here is one of the entry-level resume examples you can use: Education: Bachelor of Science in Basic MedicalSciences (GPA: 3.8)
Acting as a go-between for pharma and physicians, medicalscience liaisons (MSLs) are responsible for communicating necessary information about new medicines to healthcare professionals and key opinion leaders (KOLs). Traditionally, these detailed scientific discussions took place in person. A fresh approach.
Sales reps can practice their pitches in virtual environments, analyze customer data for tailored approaches, and stay updated with real-time information. This trend demands a deeper level of scientific knowledge and the ability to convey this information in a clear, relatable manner. They're about creating experiences that stick.
The early-stage venture financing firm Canaan Partners focuses on game-changing innovations in information, digital technologies, and the medicalsciences. Over the last 31 years, the firm has managed a highly diversified $5 billion fund that comprises some of the top names in technology and life sciences.
SUMMARY: It’s almost impossible for the average person to get accurate and reliable information from the media. We need to follow the science. The best way to get accurate health information may be to follow noted physicians on social media. Even vaccine booster shots are being debated by HCPs and Pfizer.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content